---
schema_version: "secwatch.filing_event.v1"
accession: "0001818331-25-000002"
form_type: "8-K"
ticker: "WGS"
cik: "0001818331"
company_name: "GeneDx Holdings Corp."
filed_at: "2025-01-02T23:59:59+00:00"
generated_at: "2026-05-28T18:49:42.374401+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# GeneDx appoints Bryan Dechairo as COO with $450K salary and $2.7M RSU award

## Summary
- Bryan Dechairo appointed COO effective Jan 2, 2025; reports to CEO Katherine Stueland.
- Total annual base salary of $450,000 plus target annual bonus of 50% of base salary.
- RSUs with $2.7M grant-date value vesting over 4 years; sign-on bonuses of $75K each in 2025 and 2026.
- Dechairo previously CEO of Sherlock Biosciences; will oversee Product & Technology, Operations, Medical Affairs, Innovation.

## SEC filing metadata
- accession: 0001818331-25-000002
- form_type: 8-K
- ticker: WGS
- cik: 0001818331
- company_name: GeneDx Holdings Corp.
- filed_at: 2025-01-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818331/000181833125000002/0001818331-25-000002-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818331/000181833125000002/wgs-20250102.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001818331-25-000002
- JSON: https://secwatch.observer/filing/0001818331-25-000002.json
- Plain text: https://secwatch.observer/filing/0001818331-25-000002.txt

## Key facts
- Executive change
  Bryan Dechairo was appointed as Chief Operating Officer at GeneDx Holdings Corp..
  - Action: appointed
  - Role: Chief Operating Officer
  source text: On January 2, 2025, GeneDx Holdings Corp. (the “Company”) announced the appointment of Bryan Dechairo, Ph.D., age 52, in the newly created role of Chief Operating Officer, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1818331/000181833125000002/0001818331-25-000002-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.